1. Home
  2. BNTC vs ORN Comparison

BNTC vs ORN Comparison

Compare BNTC & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • ORN
  • Stock Information
  • Founded
  • BNTC 1995
  • ORN 1994
  • Country
  • BNTC United States
  • ORN United States
  • Employees
  • BNTC N/A
  • ORN N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • ORN Military/Government/Technical
  • Sector
  • BNTC Health Care
  • ORN Industrials
  • Exchange
  • BNTC Nasdaq
  • ORN Nasdaq
  • Market Cap
  • BNTC 335.5M
  • ORN 339.4M
  • IPO Year
  • BNTC N/A
  • ORN 2007
  • Fundamental
  • Price
  • BNTC $12.99
  • ORN $6.99
  • Analyst Decision
  • BNTC Strong Buy
  • ORN Strong Buy
  • Analyst Count
  • BNTC 5
  • ORN 2
  • Target Price
  • BNTC $26.00
  • ORN $11.25
  • AVG Volume (30 Days)
  • BNTC 41.1K
  • ORN 489.8K
  • Earning Date
  • BNTC 09-25-2025
  • ORN 07-29-2025
  • Dividend Yield
  • BNTC N/A
  • ORN N/A
  • EPS Growth
  • BNTC N/A
  • ORN N/A
  • EPS
  • BNTC N/A
  • ORN 0.27
  • Revenue
  • BNTC N/A
  • ORN $837,494,000.00
  • Revenue This Year
  • BNTC N/A
  • ORN $4.34
  • Revenue Next Year
  • BNTC N/A
  • ORN $11.09
  • P/E Ratio
  • BNTC N/A
  • ORN $25.45
  • Revenue Growth
  • BNTC N/A
  • ORN 15.85
  • 52 Week Low
  • BNTC $8.06
  • ORN $4.64
  • 52 Week High
  • BNTC $17.15
  • ORN $9.95
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 58.50
  • ORN 42.45
  • Support Level
  • BNTC $12.04
  • ORN $6.44
  • Resistance Level
  • BNTC $13.09
  • ORN $6.89
  • Average True Range (ATR)
  • BNTC 0.63
  • ORN 0.29
  • MACD
  • BNTC 0.18
  • ORN 0.01
  • Stochastic Oscillator
  • BNTC 93.47
  • ORN 52.88

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.

Share on Social Networks: